Letter: Hydralazine therapy in idiopathic SLE.
D000974:Antibodies, Antinuclear; D044383:Black People; D006801:Humans; D006830:Hydralazine / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D006973:Hypertension / Q000188:drug therapy*; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced* / Q000276:immunology; D013997:Time Factors; D044465:White People
D000974:Antibodies, Antinuclear; D006830:Hydralazine